Zanidatamab plus chemotherapy with or without tislelizumab significantly improves progression free survival in first-line ...

Lonvo-z is an in vivo CRISPR gene editing candidate that is designed to inactivate the kallikrein B1 gene, thereby permanently lowering kallikrein and bradykinin levels.

About one-third of children and adolescents use dietary supplements in the US, according to a study published online April 24 in Pediatrics Open Science. Brandy ...

Treatment with three low-dose agents in single pill linked to lower incidence of recurrent stroke, major cardiovascular events in patients with hemorrhagic stroke ...

Officials say the move conflicts with past promises to limit ties between the government and the tobacco industry.

Early signs include a high fever, cough, runny nose and red, watery eyes. A red rash that starts at the hairline usually appears three to five days later. People can spread the virus from 4 days ...